Public-Private Innovation
When a private-sector technology should consider non-dilutive funding or public-private collaboration
Some private-sector technologies may benefit from evaluation against non-dilutive funding or collaboration pathways, depending on fit and eligibility.
Kepasa IP
2 min read

Certain private-sector technologies may be appropriate for evaluation against pathways such as SBIR, STTR, cooperative research and development, agency-aligned programs, or other forms of public-private collaboration. Whether any pathway fits depends on the technology, the organization, and the specific program requirements. It should be evaluated as one option within a broader commercialization strategy, not as a guaranteed source of funding.
What these pathways can offer
Depending on the program, government-supported pathways may provide:
Non-dilutive funding for research, development, or validation
Access to research partners, facilities, or technical expertise
Early demonstration opportunities with public-sector users
Credibility that can support later commercial partnerships
These benefits can be meaningful, especially for early-stage technologies that need validation before commercial partners will engage.
When it may be worth considering
Evaluation may make sense when:
The technology addresses a need aligned with an agency’s stated priorities
Additional research or validation is required before commercial adoption
The organization meets basic eligibility requirements
The owner has the capacity to manage program obligations and reporting
Public-sector collaboration would strengthen the commercial case
What to weigh carefully
These pathways also carry obligations. Owners should review:
Eligibility. Ownership, size, and organizational requirements vary by program.
Timelines. Application, review, and award cycles can be long.
Scope. Funded work must match the program’s objectives.
Intellectual-property terms. Some programs include specific rights or obligations related to inventions developed with funding.
Reporting and compliance. Ongoing administrative work is required.
Strategic fit. The funded work should advance, not distract from, the commercial plan.
How it fits the broader strategy
Government-enabled pathways work best as part of a commercialization plan, not as a substitute for one. The same questions still apply: What is the application? Who will adopt it? What partner will bring it to market?
A technology that moves through a funded research phase still needs a credible route to commercial adoption afterward.
Important caution
Programs, eligibility, and award decisions vary by agency and change over time. No outcome is guaranteed. Kepasa IP does not guarantee funding, awards, contracts, or government participation. Owners should review specific program requirements and intellectual-property terms with qualified legal, financial, and subject-matter advisors.


